KPIs & Operating Metrics(New)
Abecma Revenue By GeographyAbecma Revenue By Geography AnnualAbraxane Revenue By GeographyAbraxane Revenue By Geography AnnualBaraclude Revenue By GeographyBaraclude Revenue By Geography AnnualBreakdown Of AssetsBreyanzi Revenue By GeographyBreyanzi Revenue By Geography AnnualCamzyos Revenue By GeographyCamzyos Revenue By Geography AnnualCost Of Products SoldEliquis Revenue By GeographyEliquis Revenue By Geography AnnualEmpliciti Revenue By GeographyEmpliciti Revenue By Geography AnnualEmployee StatisticsGross Margin %Gross ProfitGross Revenue By Wholeseller %Income Before Income TaxInrebic Revenue By GeographyInrebic Revenue By Geography AnnualMature And Other Products Revenue By GeographyMature And Other Products Revenue By Geography AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Onureg Revenue By GeographyOnureg Revenue By Geography AnnualOpdivo Ex U.S Sales Mix %Opdivo Revenue By GeographyOpdivo Revenue By Geography AnnualOpdivo U.S Sales Mix %Opdualag Revenue By GeographyOpdualag Revenue By Geography AnnualOperating Expense SegregationOpex As A % Of Total Revenue %Orencia Revenue By GeographyOrencia Revenue By Geography AnnualOther Brands Revenue By GeographyOther Brands Revenue By Geography AnnualPomalyst/Imnovid Revenue By GeographyPomalyst/Imnovid Revenue By Geography AnnualProduct SalesProduct Sales Mix %Property, Plant & Equipment BreakdownR&D Locations By Geographic AreaReblozyl Revenue By GeographyReblozyl Revenue By Geography AnnualRemaining Performance ObligationRevenue By BrandRevenue By Brand %Revenue By Brand AnnualRevenue By Brand Annual %Revenue By CategoryRevenue By Category %Revenue By Category AnnualRevenue By Category Annual %Revenue By ProductRevenue By Product %Revenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment AnnualRevenue By Segment Annual %Revlimid Revenue By GeographyRevlimid Revenue By Geography AnnualSotyktu Revenue By GeographySotyktu Revenue By Geography AnnualSprycel Revenue By GeographySprycel Revenue By Geography AnnualVidaza Revenue By GeographyVidaza Revenue By Geography AnnualYervoy Revenue By GeographyYervoy Revenue By Geography AnnualZeposia Revenue By GeographyZeposia Revenue By Geography Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Gross Profit (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Gross Profit for 17 consecutive years, with $8.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 11.62% to $8.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $34.3 billion, a 0.22% change, with the full-year FY2025 number at $34.3 billion, changed 0.22% from a year prior.
  • Gross Profit was $8.4 billion for Q4 2025 at Bristol Myers Squibb, down from $8.8 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $9.6 billion in Q4 2021 to a low of $7.5 billion in Q4 2024.
  • A 5-year average of $8.8 billion and a median of $8.8 billion in 2022 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: increased 24.51% in 2021, then fell 13.77% in 2024.
  • Bristol Myers Squibb's Gross Profit stood at $9.6 billion in 2021, then decreased by 8.47% to $8.8 billion in 2022, then fell by 0.92% to $8.7 billion in 2023, then dropped by 13.77% to $7.5 billion in 2024, then grew by 11.62% to $8.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Gross Profit are $8.4 billion (Q4 2025), $8.8 billion (Q3 2025), and $8.9 billion (Q2 2025).